Showing results (81-90 of 225) with videos related to

Sort By:
Pageof 23
Oncology|November 7, 2012
Multimodality treatment of gynecomastia in patients receiving antiandrogen therapy for prostate cancer in the era of abiraterone acetate and new antiandrogen moleculesDaniele Alesini, Roberto Iacovelli, Antonella Palazzo, et al.
Cancer Treatment Reviews|October 10, 2017
Adjuvant therapy in renal cell carcinomaFrancesco Massari, Vincenzo Di Nunno, Chiara Ciccarese, et al.
Cancer Treatment Reviews|March 21, 2022
New first-line immunotherapy-based combinations for metastatic renal cell carcinoma: A systematic review and network meta-analysisPasquale Lombardi, Marco Filetti, Rosa Falcone, et al.
International Journal of Cancer|October 16, 2013
Risk of gastrointestinal events with sorafenib, sunitinib and pazopanib in patients with solid tumors: a systematic review and meta-analysis of clinical trialsMatteo Santoni, Alessandro Conti, Ugo De Giorgi, et al.
Future Oncology (London, England)|June 18, 2016
Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: part 1 - kidney cancerSebastiano Buti, Chiara Ciccarese, Roberto Iacovelli, et al.
Future Oncology (London, England)|June 18, 2016
Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: part 2 - prostate and bladder cancerSebastiano Buti, Chiara Ciccarese, Roberto Iacovelli, et al.
Prostate Cancer and Prostatic Diseases|November 6, 2019
Adverse events related to abiraterone and enzalutamide treatment: analysis of the EudraVigilance database and meta-analysis of registrational phase III studiesCosimo De Nunzio, Riccardo Lombardo, Giorgia Tema, et al.
Cancer Metastasis Reviews|September 14, 2015
The origin of prostate metastases: emerging insightsMatteo Santoni, Francesco Piva, Marina Scarpelli, et al.
Urologic Oncology|June 18, 2023
Meta-analysis of perioperative immunotherapy in renal cell carcinoma: Available, but the jury is still outJorge Esteban-Villarrubia, Carmen Romero Ferreiro, Lucía Carril-Ajuria, et al.
Anticancer Research|December 27, 2011
Circulating tumor cells and "suspicious objects" evaluated through CellSearch® in metastatic renal cell carcinomaAngela Gradilone, Roberto Iacovelli, Enrico Cortesi, et al.
Pageof 23